BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32213057)

  • 1. Diagnostic delay does not influence survival of pancreatic cancer patients.
    Stornello C; Archibugi L; Stigliano S; Vanella G; Graglia B; Capalbo C; Nigri G; Capurso G
    United European Gastroenterol J; 2020 Feb; 8(1):81-90. PubMed ID: 32213057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Misdiagnosis of Proximal Pancreatic Adenocarcinoma Is Associated with Delay in Diagnosis and Advanced Stage at Presentation.
    Swords DS; Mone MC; Zhang C; Presson AP; Mulvihill SJ; Scaife CL
    J Gastrointest Surg; 2015 Oct; 19(10):1813-21. PubMed ID: 26286368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer.
    Gobbi PG; Bergonzi M; Comelli M; Villano L; Pozzoli D; Vanoli A; Dionigi P
    Cancer Epidemiol; 2013 Apr; 37(2):186-90. PubMed ID: 23369450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
    Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
    Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
    Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
    Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: current understanding of molecular and genetic aetiologies.
    Gall TM; Wasan H; Jiao LR
    Postgrad Med J; 2015 Oct; 91(1080):594-600. PubMed ID: 26124188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic ductal adenocarcinoma presenting with acute and chronic pancreatitis as initial presentation: is prognosis better? A comparison study.
    Thorat A; Huang WH; Yeh TS; Jan YY; Hwang TL
    Hepatogastroenterology; 2014 Oct; 61(135):2110-6. PubMed ID: 25713917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
    Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
    Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
    J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
    Honselmann KC; Elser Y; Boeckmann T; Bolm L; Winkel MT; Deichmann S; Braun R; Wellner UF; Keck T; Lapshyn H
    Surgery; 2023 Sep; 174(3):674-683. PubMed ID: 37349251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure.
    Aslani A; Gill AJ; Roach PJ; Allen BJ; Smith RC
    HPB (Oxford); 2010 Jun; 12(5):325-33. PubMed ID: 20590908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.